Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Characteristics of amorphous complex formed between indomethacin and lidocaine hydrochloride.

Shimada Y, Goto S, Uchiro H, Hirota K, Terada H.

Colloids Surf B Biointerfaces. 2013 May 1;105:98-105. doi: 10.1016/j.colsurfb.2012.12.026. Epub 2012 Dec 31.

PMID:
23352941
[PubMed - indexed for MEDLINE]
2.

Features of heat-induced amorphous complex between indomethacin and lidocaine.

Shimada Y, Goto S, Uchiro H, Hirabayashi H, Yamaguchi K, Hirota K, Terada H.

Colloids Surf B Biointerfaces. 2013 Feb 1;102:590-6. doi: 10.1016/j.colsurfb.2012.08.060. Epub 2012 Sep 13. Erratum in: Colloids Surf B Biointerfaces. 2013 Mar 1;103:664-5.

PMID:
23104030
[PubMed - indexed for MEDLINE]
3.

Estimation of the fragility index of indomethacin by DSC using the heating and cooling rate dependency of the glass transition.

Ramos JJ, Taveira-Marques R, Diogo HP.

J Pharm Sci. 2004 Jun;93(6):1503-7.

PMID:
15124208
[PubMed - indexed for MEDLINE]
4.

Investigations on the effect of different cooling rates on the stability of amorphous indomethacin.

Karmwar P, Boetker JP, Graeser KA, Strachan CJ, Rantanen J, Rades T.

Eur J Pharm Sci. 2011 Oct 9;44(3):341-50. doi: 10.1016/j.ejps.2011.08.010. Epub 2011 Aug 23.

PMID:
21884789
[PubMed - indexed for MEDLINE]
5.

Characterization of multicomponent crystal formed between indomethacin and lidocaine.

Umeda Y, Fukami T, Furuishi T, Suzuki T, Tanjoh K, Tomono K.

Drug Dev Ind Pharm. 2009 Jul;35(7):843-51. doi: 10.1080/03639040802660489.

PMID:
19466900
[PubMed - indexed for MEDLINE]
6.

Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.

Yoshioka M, Hancock BC, Zografi G.

J Pharm Sci. 1994 Dec;83(12):1700-5.

PMID:
7891297
[PubMed - indexed for MEDLINE]
7.

Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.

Chieng N, Aaltonen J, Saville D, Rades T.

Eur J Pharm Biopharm. 2009 Jan;71(1):47-54. doi: 10.1016/j.ejpb.2008.06.022. Epub 2008 Jul 3.

PMID:
18644443
[PubMed - indexed for MEDLINE]
8.

Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR.

Apperley DC, Forster AH, Fournier R, Harris RK, Hodgkinson P, Lancaster RW, Rades T.

Magn Reson Chem. 2005 Nov;43(11):881-92.

PMID:
16059964
[PubMed - indexed for MEDLINE]
9.

Glass transition behavior of octyl β-D-glucoside and octyl β-D-thioglucoside/water binary mixtures.

Ogawa S, Asakura K, Osanai S.

Carbohydr Res. 2010 Nov 22;345(17):2534-41. doi: 10.1016/j.carres.2010.08.004. Epub 2010 Aug 19.

PMID:
20889145
[PubMed - indexed for MEDLINE]
10.

Solid-state characteristics of amorphous sodium indomethacin relative to its free acid.

Tong P, Zografi G.

Pharm Res. 1999 Aug;16(8):1186-92.

PMID:
10468018
[PubMed - indexed for MEDLINE]
11.

Molecular complex consisting of two typical external medicines: intermolecular interaction between indomethacin and lidocaine.

Umeda Y, Fukami T, Furuishi T, Suzuki T, Makimura M, Tomono K.

Chem Pharm Bull (Tokyo). 2007 May;55(5):832-6.

PMID:
17473482
[PubMed - indexed for MEDLINE]
Free Article
12.

Molecular dynamics studies on the water mixtures of pharmaceutically important ionic liquid lidocaine HCl.

Wojnarowska Z, Grzybowska K, Hawelek L, Swiety-Pospiech A, Masiewicz E, Paluch M, Sawicki W, Chmielewska A, Bujak P, Markowski J.

Mol Pharm. 2012 May 7;9(5):1250-61. doi: 10.1021/mp2005609. Epub 2012 Mar 26.

PMID:
22424553
[PubMed - indexed for MEDLINE]
13.

Comparison between polyvinylpyrrolidone and silica nanoparticles as carriers for indomethacin in a solid state dispersion.

Watanabe T, Hasegawa S, Wakiyama N, Kusai A, Senna M.

Int J Pharm. 2003 Jan 2;250(1):283-6.

PMID:
12480293
[PubMed - indexed for MEDLINE]
14.

Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability.

Crowley KJ, Zografi G.

J Pharm Sci. 2002 Feb;91(2):492-507.

PMID:
11835208
[PubMed - indexed for MEDLINE]
15.

Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.

Löbmann K, Laitinen R, Grohganz H, Gordon KC, Strachan C, Rades T.

Mol Pharm. 2011 Oct 3;8(5):1919-28. doi: 10.1021/mp2002973. Epub 2011 Aug 15.

PMID:
21815614
[PubMed - indexed for MEDLINE]
16.

Characterisation of the glass transition of an amorphous drug using modulated DSC.

Royall PG, Craig DQ, Doherty C.

Pharm Res. 1998 Jul;15(7):1117-21.

PMID:
9688069
[PubMed - indexed for MEDLINE]
17.

Evaluation of the physicochemical characteristics of crospovidone that influence solid dispersion preparation.

Nakanishi S, Fujii M, Sugamura Y, Suzuki A, Shibata Y, Koizumi N, Watanabe Y.

Int J Pharm. 2011 Jul 15;413(1-2):119-25. doi: 10.1016/j.ijpharm.2011.04.050. Epub 2011 Apr 23.

PMID:
21549186
[PubMed - indexed for MEDLINE]
18.

Physical stability and relaxation of amorphous indomethacin.

Vyazovkin S, Dranca I.

J Phys Chem B. 2005 Oct 6;109(39):18637-44.

PMID:
16853398
[PubMed - indexed for MEDLINE]
19.

Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP.

Lu Q, Zografi G.

Pharm Res. 1998 Aug;15(8):1202-6.

PMID:
9706050
[PubMed - indexed for MEDLINE]
20.

A new high-temperature transition of crystalline cholesterol in mixtures with phosphatidylserine.

Epand RM, Bach D, Epand RF, Borochov N, Wachtel E.

Biophys J. 2001 Sep;81(3):1511-20.

PMID:
11509364
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk